 DUBLIN--BUSINESS WIRE--ICON plc, NASDAQ:ICLR, a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries and government and public health organisations, today announced it provided clinical trial services to the Pfizer NYSE:PFE and BioNTech SE Nasdaq: BNTX investigational COVID-19 vaccine programme. Pfizer and BioNTech were the first to announce positive efficacy results from a Phase 3, la 